Developer docs
API playgroundTry for free, no card

Search company profiles

Applied Cells

Full company profile

uuid0008q9j

Namestring
Applied Cells
Legal namestring
Applied Cells Inc.
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSanta Clara, United States
HQ citystring
Santa Clara
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cell separation instruments, immunomagnetic isolation, CAR-T manufacturing, cell therapy reagents, sample preparation systems
Industry2 codes
PRIMARYHLAAABAG
Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Cell Separation and Cell Therapy Manufacturing Instruments
Social media profiles2 records
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1MARS Instruments
TypeHardware Sales
Description

Sale of MARS Bar, MARS Bar Flex, MARS SP, and MARS CS instruments for cell separation and sample preparation applications.

appliedcells.com
2Reagent Kits
TypeOne Time License
Description

Sale of MARS Ingenuity, MARS MAG Line, and MARS MAG Premium Line reagent kits including RUO and GMP-grade beads for various cell isolation applications.

appliedcells.com
3Consumables
TypeHardware Sales
Description

Recurring sales of sterile fluidics tubing sets, containment bags, and other single-use consumables for MARS instruments.

appliedcells.com
4GoFast CAR-T Kit
TypeOne Time License
Description

Complete end-to-end kit for rapid CAR-T manufacturing including consumables and off-the-shelf CD19 LVV for pre-clinical testing.

appliedcells.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure
Pricing details2 tiers
1GoFast CAR-T Kit Early Access - Complete CAR-T manufacturing kit
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

All-in-one solution for rapid CAR-T production in less than 72 hours, starting with T cell selection from fresh leukapheresis up to 2B total cells. Includes complete consumables and off-the-shelf CD19 LVV.

appliedcells.com
2CellQuest Research Grant - Multiple Myeloma Research Support
ModelOtherBilling cadenceMulti-year contract
Notes

Grant package valued over $30,000 including 6-month MARS Bar instrument placement, reagent and consumable supply up to $8,000, comprehensive training, application development support, and ongoing Application Scientist assistance.

appliedcells.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1MARS
Description

Platform technology family for cell separation including MARS Bar, MARS Bar Flex, MARS Atlas, MARS CS, and MARS SP instruments

appliedcells.com
+5 more records
Core offering1 text field

Applied Cells designs, manufactures, and sells the MARS platform — column-free immunomagnetic cell separation instruments (MARS Bar, MARS Bar Flex, MARS Atlas, MARS SP, MARS CS) together with associated reagent kits, sterile fluidics, and the GoFast CAR-T manufacturing workflow and kit — to support cell therapy development, diagnostics, and life-science research. The offering is sold primarily to pharmaceutical, biotech, and academic customers via direct sales, regional distributors, and early-access programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • GoFast workflow produces CAR-T cells in under 72 hours vs traditional 2-3 weeks
+7 more records
Product overview1 text field

Applied Cells offers the MARS® platform, a comprehensive cell separation and isolation system comprising multiple instruments (MARS® Bar, MARS® Bar Flex, MARS® Atlas, MARS® SP, MARS® CS) and three reagent lines (Ingenuity™, MAG Line, MAG Premium Line). The platform uses proprietary column-free immunomagnetic separation technology for automated, gentle cell isolation with high purity and recovery. Key offerings include GoFast™ CAR-T workflow/kit for rapid CAR-T manufacturing in under 72 hours targeting <$10K cost of goods. The portfolio serves cell therapy development, diagnostics, genomics sample preparation, and cancer research applications.

Product and service10 records
1MARS® Bar Instrument
CategoryCell Separation Instrument (Capital Equipment)
Description

Automated, ISO 13485:2016-certified column-free immunomagnetic cell separation instrument for GMP-compatible positive and negative cell selection workflows in cell therapy development. Targeted at pharmaceutical, biotech, and academic cell therapy developers.

2MARS® Bar Flex Instrument
CategoryCell Separation Instrument (Research Equipment)
Description

Flexible research-grade column-free cell separation system that independently processes 1–3 samples at a time with high purity and recovery, aimed at academic and translational research labs.

3MARS® Atlas Instrument
CategoryCell Therapy Manufacturing Instrument
Description

End-to-end automated, closed-system instrument for rapid CAR-T cell therapy manufacturing, executing isolation, transduction, and purification to produce CAR-T cells within 24–48 hours. Targeted at cell therapy developers scaling clinical and commercial manufacturing.

4MARS® SP (Sample Preparation) Instrument
CategorySample Preparation Instrument
Description

Acoustic-based label-free sample preparation instrument for gentle cell washing, debris removal, and cell concentration without centrifugation, suitable for genomics sample prep, flow cytometry pre-enrichment, and delicate cell types.

5MARS® CS (Cell Separation) Instrument
CategoryCell Separation Instrument (Research Equipment)
Description

Integrated cell separation system combining label-free acoustic sample preparation with immuno-magnetic selection, providing flexible assay optimization for researchers developing cell isolation protocols.

6GoFast™ CAR-T Manufacturing Workflow
CategoryCell Therapy Manufacturing Workflow / Process Solution
Description

End-to-end CAR-T manufacturing workflow that compresses traditional 2–3 week timelines to under 72 hours while targeting a cost of goods under $10,000, designed for cell therapy developers readying for clinical and commercial production.

7GoFast™ CAR-T Kit
CategoryCell Therapy Consumables Kit
Description

All-in-one end-to-end kit for rapid CAR-T manufacturing under 72 hours, including complete consumables and off-the-shelf CD19 lentiviral vector, designed for use with the MARS Bar system in B+A/C+A cleanroom environments and targeting COGS below $10,000.

8MARS® Ingenuity™ Reagents
CategoryCell Isolation Reagents (Consumables)
Description

Biodegradable immunomagnetic reagent kits using 50nm superparamagnetic nanobeads and 4.5μm microbeads, available in both RUO and GMP grades, supporting cell isolation workflows for cell therapy developers. Includes CD34, TCR α/β, and CD56 GMP-grade nanobeads.

9MARS® MAG Line Reagents
CategoryCell Isolation Reagents (Consumables)
Description

Anti-PE Magnetic Nanobead-based reagent line enabling fast, no-wash, column-free isolation of PE-labeled white blood cell subpopulations such as T cells, B cells, monocytes, neutrophils, and rare cells for research and diagnostic use.

10MARS® MAG Premium Line Reagents
CategoryCell Isolation Reagents (Consumables)
Description

Premium cell separation reagent kits co-developed with STEMCELL Technologies, providing high-purity kits for granulocytes, NK cells, plasma cells, and other cell types with protocols optimized for MARS instruments.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-05
Description

Collaboration to integrate fast QC release solutions with Applied Cells' GoFast CAR-T manufacturing workflow, enabling accelerated quality control testing for CAR-T cell therapy production.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-13
Description

Strategic collaboration framework to jointly advance affordable CAR-T therapies, combining Applied Cells' manufacturing technology with Immuneel's expertise in cell therapy development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched MARS MAG Premium Line of reagents in collaboration with STEMCELL Technologies, offering optimized kits for cell isolation including granulocytes, NK cells, and plasma cells with protocols designed for MARS instruments.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic collaboration to deliver combined solutions for cell therapy development, integrating Applied Cells' MARS platform with GenScript's synthetic biology and cell therapy tools.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Collaborative marketing agreement to provide a powerful tumor biology solution combining Applied Cells' MARS platform with S2 Genomics' tissue sample preparation technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

MARS platform showcased at the opening of new CREATIC Centre of Excellence facilities at Masaryk University in Brno, supporting advanced cell therapy research in Central Europe.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Evaluation agreement for new MARS platform technology at UPenn's cell therapy research facilities to assess performance for various cell isolation applications.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance6 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Applied Cells

Cell Separation and Cell Therapy Manufacturing Instrumentsappliedcells.com

Applied Cells firmographics

Firmographics
Name
Applied Cells
Legal name
Applied Cells Inc.
Website
https://appliedcells.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Applied Cells industry classification

Industry
Product category
Cell Separation and Cell Therapy Manufacturing Instruments
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAAABAG
Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Cell separation instruments
  • Immunomagnetic isolation
  • CAR-T manufacturing
  • Cell therapy reagents
  • Sample preparation systems

Where Applied Cells is headquartered

Location

Headquarters

HQ city
Santa Clara
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Applied Cells business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. MARS Instruments: Sale of MARS Bar, MARS Bar Flex, MARS SP, and MARS CS instruments for cell separation and sample preparation applications.
  2. Reagent Kits: Sale of MARS Ingenuity, MARS MAG Line, and MARS MAG Premium Line reagent kits including RUO and GMP-grade beads for various cell isolation applications.
  3. Consumables: Recurring sales of sterile fluidics tubing sets, containment bags, and other single-use consumables for MARS instruments.
  4. GoFast CAR-T Kit: Complete end-to-end kit for rapid CAR-T manufacturing including consumables and off-the-shelf CD19 LVV for pre-clinical testing.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goGoFast CAR-T Kit Early Access - Complete CAR-T manufacturing kit
OtherMulti-year contractCellQuest Research Grant - Multiple Myeloma Research Support

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Applied Cells product offering

Product offering

Core offering

Applied Cells designs, manufactures, and sells the MARS platform — column-free immunomagnetic cell separation instruments (MARS Bar, MARS Bar Flex, MARS Atlas, MARS SP, MARS CS) together with associated reagent kits, sterile fluidics, and the GoFast CAR-T manufacturing workflow and kit — to support cell therapy development, diagnostics, and life-science research. The offering is sold primarily to pharmaceutical, biotech, and academic customers via direct sales, regional distributors, and early-access programs.

Product overview

Applied Cells offers the MARS® platform, a comprehensive cell separation and isolation system comprising multiple instruments (MARS® Bar, MARS® Bar Flex, MARS® Atlas, MARS® SP, MARS® CS) and three reagent lines (Ingenuity™, MAG Line, MAG Premium Line). The platform uses proprietary column-free immunomagnetic separation technology for automated, gentle cell isolation with high purity and recovery. Key offerings include GoFast™ CAR-T workflow/kit for rapid CAR-T manufacturing in under 72 hours targeting <$10K cost of goods. The portfolio serves cell therapy development, diagnostics, genomics sample preparation, and cancer research applications.

Differentiator

Problem solved

Functional benefit

Brands

  • MARS: Platform technology family for cell separation including MARS Bar, MARS Bar Flex, MARS Atlas, MARS CS, and MARS SP instruments
  • GoFast
  • MARS Ingenuity
  • MARS MAG Line
  • MARS MAG Premium Line
  • Ingenuity

Products and services

  • MARS® Bar Instrument Automated, ISO 13485:2016-certified column-free immunomagnetic cell separation instrument for GMP-compatible positive and negative cell selection workflows in cell therapy development. Targeted at pharmaceutical, biotech, and academic cell therapy developers.
  • MARS® Bar Flex Instrument Flexible research-grade column-free cell separation system that independently processes 1–3 samples at a time with high purity and recovery, aimed at academic and translational research labs.
  • MARS® Atlas Instrument End-to-end automated, closed-system instrument for rapid CAR-T cell therapy manufacturing, executing isolation, transduction, and purification to produce CAR-T cells within 24–48 hours. Targeted at cell therapy developers scaling clinical and commercial manufacturing.
  • MARS® SP (Sample Preparation) Instrument Acoustic-based label-free sample preparation instrument for gentle cell washing, debris removal, and cell concentration without centrifugation, suitable for genomics sample prep, flow cytometry pre-enrichment, and delicate cell types.
  • MARS® CS (Cell Separation) Instrument Integrated cell separation system combining label-free acoustic sample preparation with immuno-magnetic selection, providing flexible assay optimization for researchers developing cell isolation protocols.
  • GoFast™ CAR-T Manufacturing Workflow End-to-end CAR-T manufacturing workflow that compresses traditional 2–3 week timelines to under 72 hours while targeting a cost of goods under $10,000, designed for cell therapy developers readying for clinical and commercial production.
  • GoFast™ CAR-T Kit All-in-one end-to-end kit for rapid CAR-T manufacturing under 72 hours, including complete consumables and off-the-shelf CD19 lentiviral vector, designed for use with the MARS Bar system in B+A/C+A cleanroom environments and targeting COGS below $10,000.
  • MARS® Ingenuity™ Reagents Biodegradable immunomagnetic reagent kits using 50nm superparamagnetic nanobeads and 4.5μm microbeads, available in both RUO and GMP grades, supporting cell isolation workflows for cell therapy developers. Includes CD34, TCR α/β, and CD56 GMP-grade nanobeads.
  • MARS® MAG Line Reagents Anti-PE Magnetic Nanobead-based reagent line enabling fast, no-wash, column-free isolation of PE-labeled white blood cell subpopulations such as T cells, B cells, monocytes, neutrophils, and rare cells for research and diagnostic use.
  • MARS® MAG Premium Line Reagents Premium cell separation reagent kits co-developed with STEMCELL Technologies, providing high-purity kits for granulocytes, NK cells, plasma cells, and other cell types with protocols optimized for MARS instruments.

Quantifiable outcome

  • GoFast workflow produces CAR-T cells in under 72 hours vs traditional 2-3 weeks
  • +7 more outcomes

Companies that use Applied Cells

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Applied Cells technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Applied Cells partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • SHENTEKcoreStrategic or Co-development Partner · 5 May 2026Collaboration to integrate fast QC release solutions with Applied Cells' GoFast CAR-T manufacturing workflow, enabling accelerated quality control testing for CAR-T cell therapy production.
  • Immuneel TherapeuticscoreStrategic or Co-development Partner · 13 January 2026Strategic collaboration framework to jointly advance affordable CAR-T therapies, combining Applied Cells' manufacturing technology with Immuneel's expertise in cell therapy development.
  • STEMCELL TechnologiescoreStrategic or Co-development PartnerLaunched MARS MAG Premium Line of reagents in collaboration with STEMCELL Technologies, offering optimized kits for cell isolation including granulocytes, NK cells, and plasma cells with protocols designed for MARS instruments.
  • GenScriptminorStrategic or Co-development PartnerStrategic collaboration to deliver combined solutions for cell therapy development, integrating Applied Cells' MARS platform with GenScript's synthetic biology and cell therapy tools.
  • S2 GenomicsminorGTM or Marketing PartnerCollaborative marketing agreement to provide a powerful tumor biology solution combining Applied Cells' MARS platform with S2 Genomics' tissue sample preparation technology.
  • Masaryk University CREATIC Centre of ExcellenceminorStrategic or Co-development PartnerMARS platform showcased at the opening of new CREATIC Centre of Excellence facilities at Masaryk University in Brno, supporting advanced cell therapy research in Central Europe.
  • University of PennsylvaniaminorStrategic or Co-development PartnerEvaluation agreement for new MARS platform technology at UPenn's cell therapy research facilities to assess performance for various cell isolation applications.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Applied Cells competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Applied Cells social profiles

Digital presence

Applied Cells compliance and trust

Trust signal

Compliance6 records

Applied Cells financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Applied Cells leadership team

Management profile

Number of profiles

Profiles1 record

Applied Cells funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Applied Cells M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Applied Cells

What does Applied Cells do?

Applied Cells designs, manufactures, and sells the MARS platform — column-free immunomagnetic cell separation instruments (MARS Bar, MARS Bar Flex, MARS Atlas, MARS SP, MARS CS) together with associated reagent kits, sterile fluidics, and the GoFast CAR-T manufacturing workflow and kit — to support cell therapy development, diagnostics, and life-science research. The offering is sold primarily to pharmaceutical, biotech, and academic customers via direct sales, regional distributors, and early-access programs.

Is Applied Cells a public or private company?

Applied Cells is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Applied Cells founded?

Applied Cells was founded in 2016. It employs 11 to 50 people.

Where is Applied Cells based?

Applied Cells is headquartered in Santa Clara, United States, in the North America region.

How does Applied Cells make money?

Four revenue lines are on record. MARS Instruments are the primary driver. The others are reagent Kits, consumables and goFast CAR-T Kit.

Does Applied Cells have an API?

No public API is recorded for Applied Cells.

What industry is Applied Cells in?

Applied Cells's product category is Cell Separation and Cell Therapy Manufacturing Instruments. Its primary akta.pro industry code is HLAAABAG, Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish), with a secondary code of HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables). Its NAICS code is 33451 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireApplied Cells and Immuneel Therapeutics Announce Strategic Collaboration to Advance Truly Affordable CAR-T Cell Therapies in India and GloballyApplied Cells Inc. and Immuneel Therapeutics Private Limited announced a strategic collaboration to evaluate the application of Applied Cells' MARS® Atlas platform and GoFast™ CAR-T workflow for developing and manufacturing affordable CAR-T cell therapies for cancer patients. The partnership aims to achieve manufacturing costs that enable affordable CAR-T therapy in India while maintaining therapeutic efficacy comparable to approved treatments, with the goal of broader global adoption. Both companies have commenced collaborative activities and will provide further updates as programs progress.News-MedicalApplied Cells releases game-changing reagent kits to empower cell therapy developmentApplied Cells launched MARS Ingenuity reagent kits for cell isolation, featuring RUO and GMP-grade reagents optimized for its MARS Bar platform. The kits enable immunomagnetic separation at up to 6 ml/min, supporting CAR-T and CAR-macrophage therapies. The company plans to bring additional Ingenuity products to market.PR NewswireApplied Cells Inc. and GenScript Enter Strategic Collaboration to Deliver Combined Solutions for Cell Therapy DevelopmentApplied Cells Inc. and GenScript USA Incorporated announced a strategic collaboration to integrate GenScript's CytoSinct™ reagents into Applied Cells' MARS® platform for cell therapy development. This partnership aims to provide combined, high-efficiency solutions for isolating cells used in developing CAR-T and other cell therapy products. Both companies will support GMP-compliant documentation for the developed products.PR NewswireApplied Cells Inc. Enters Collaborative Marketing Agreement with S2 Genomics Inc. to Provide a Powerful Tumor Biology Solution in Tissue Sample PreparationApplied Cells Inc. and S2 Genomics Inc. announced a joint marketing agreement to combine their respective technologies for tumor biology research workflow solutions. The partnership integrates S2 Genomics' Singulator 100 System for tissue dissociation with Applied Cells' MARS Acoustics and Magnetic technologies for cell isolation, creating an automated end-to-end tissue sample preparation platform. The combined solution aims to deliver high-purity, high-recovery single cells or nuclei for downstream analytics such as single cell sequencing and flow cytometry.PR NewswireApplied Cells Inc. Today Unveils Its GMP-Ready MARS® Bar System, a Revolutionary Cell Isolation System for Cell and Gene TherapyApplied Cells Inc. announced the unveiling of its GMP-Ready MARS® Bar System, a magnetic cell isolation technology designed for cell and gene therapy applications, at the SLAS Conference in Boston on February 7, 2022. The system features an enclosed bag-in-bag-out configuration compatible with sterile processing and is being released to select customers via an Early Access Program. This launch responds to customer demand for higher capacity solutions utilizing the company's proprietary cell separation technologies.PR NewswireApplied Cells Inc. Introduces the Offering of MARS® MAG Line Reagents for Complete Turnkey Solutions to Cell IsolationApplied Cells Inc. announced the release of its MARS MAG Line of magnetic labeling reagents for cell isolation, expanding turnkey solutions for its MARS Platforms. The products are designed to achieve high purity, high recovery, and high reproducibility for applications in tumor biology, genomics analysis, and cell therapeutic development. Additional MARS MAG Line products including antibodies and other reagents will become available in coming months.PR NewswireApplied Cells Announces New MARS® Bar SystemApplied Cells, Inc. announced the launch of its MARS® Bar System, a fully automated high-capacity closed system for cell processing, as part of an Early Access Program. The system enables magnetic cell isolation for large volume blood and bone marrow cell products to support immunotherapeutic development and sterile cell culture. CEO Yuchen Zhou noted strong customer demand following the June launch of the company's earlier MARS® CS and SP systems, with the new product designed to address the need for higher capacity solutions.PR NewswireApplied Cells Announces Evaluation of Its New MARS Platform at The University of PennsylvaniaApplied Cells Inc. and the University of Pennsylvania have entered into a Collaborative Research Agreement to evaluate Applied Cells' new MARS cell isolation and sample preparation system in cancer and immunology research. The MARS platform offers high-throughput, high-efficiency, high-recovery automated cell separation capabilities for rare cell analysis, immune cell profiling, and cell therapy applications. The collaboration aims to enable researchers at Penn to identify rare populations for diagnostic markers and potentially isolate new cellular therapeutics using the MARS system.